Mei‐Yong Li

m(6)A Modification of lncRNA NEAT1 Regulates Chronic Myelocytic Leukemia Progression via miR-766-5p/CDKN1A Axis

Fangyi Yao, Cui Zhao, Fangmin Zhong et al. · Frontiers in Oncology · 2021 · 43 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients

Mei‐Yong Li, Zhao Cui, Lian Chen et al. · Frontiers in Oncology · 2021 · 35 citations · Full text

Medicine, Molecular Biology, Oncology +17

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia

Fangmin Zhong, Fangyi Yao, Jing Liu et al. · Frontiers in Oncology · 2022 · 20 citations · Full text

Medicine, Immunology, Oncology +16

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia

Fangmin Zhong, Fangyi Yao, Yu‐Lin Yang et al. · Cancer Cell International · 2023 · 14 citations · Full text

Life Sciences, Hematology, Immunology +17

H19 contributes to poor clinical features in NSCLC patients and leads to enhanced invasion in A549 cells through regulating miRNA‑203‑mediated epithelial‑mesenchymal transition

Xiaojun Ge, Limei Zheng, Zhongxin Feng et al. · Oncology Letters · 2018 · 13 citations · Full text

Medicine, Cancer Biology, Oncology +14